mRNA |
neratinib |
CTRPv2 |
pan-cancer |
AAC |
0.016 |
0.6 |
mRNA |
BIRB 0796 |
CTRPv2 |
pan-cancer |
AAC |
-0.018 |
0.6 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.016 |
0.6 |
mRNA |
BRD9876:MK-1775 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.049 |
0.6 |
mRNA |
C6-ceramide |
CTRPv2 |
pan-cancer |
AAC |
0.017 |
0.6 |
mRNA |
WP1130 |
CTRPv2 |
pan-cancer |
AAC |
0.016 |
0.6 |
mRNA |
RG-108 |
CTRPv2 |
pan-cancer |
AAC |
-0.016 |
0.6 |
mRNA |
Bortezomib |
CTRPv2 |
pan-cancer |
AAC |
-0.015 |
0.7 |
mRNA |
CIL55 |
CTRPv2 |
pan-cancer |
AAC |
-0.027 |
0.7 |
mRNA |
KU-0063794 |
CTRPv2 |
pan-cancer |
AAC |
0.016 |
0.7 |